(Q34309476)

1 August 2017

0 references

Meta-analysis of the effect of placebo on the outcome of medically treated reflux esophagitis (English)

1 reference

1 August 2017

0 references

1 reference

Pace F

1

1 reference

1 August 2017

Maconi G

2

1 reference

1 August 2017

Molteni P

3

1 reference

1 August 2017

Minguzzi M

4

1 reference

1 August 2017

Bianchi Porro G

5

1 reference

1 August 2017

publication date

1 February 1995

1 reference

Scandinavian Journal of Gastroenterology

1 August 2017

published in

1 reference

1 August 2017

volume

30

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

101-105

1 reference

Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Meta-analyses of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Treatment of reflux oesophagitis with cimetidine (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Treatment of reflux oesophagitis with ranitidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Sucralfate versus placebo in reflux esophagitis. A double-blind multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Pirenzepine in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Effect of cimetidine in symptomatic gastro-oesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

The hiatus hernia-esophagitis-esophageal stricture complex. Twenty-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Severe peptic oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Controlled trial of pyrogastrone and cimetidine in the treatment of reflux oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Three year follow up of patients with gastrooesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

Treatment of reflux oesophagitis with trimoprostil

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093245

10.3109/00365529509093245

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference